Citation

BibTex format

@article{Cabrera-Fuentes:2016:10.1007/s00395-016-0586-x,
author = {Cabrera-Fuentes, HA and Aragones, J and Bernhagen, J and Boening, A and Boisvert, WA and Bøtker, HE and Bulluck, H and Cook, S and Di, Lisa F and Engel, FB and Engelmann, B and Ferrazzi, F and Ferdinandy, P and Fong, A and Fleming, I and Gnaiger, E and Hernández-Reséndiz, S and Kalkhoran, SB and Kim, MH and Lecour, S and Liehn, EA and Marber, MS and Mayr, M and Miura, T and Ong, S-B and Peter, K and Sedding, D and Singh, MK and Suleiman, MS and Schnittler, HJ and Schulz, R and Shim, W and Tello, D and Vogel, C-W and Walker, M and Li, QOY and Yellon, DM and Hausenloy, DJ and Preissner, KT},
doi = {10.1007/s00395-016-0586-x},
journal = {Basic Research in Cardiology},
title = {From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research"},
url = {http://dx.doi.org/10.1007/s00395-016-0586-x},
volume = {111},
year = {2016}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - In this meeting report, particularly addressing the topic of protection of the cardiovascular system from ischemia/reperfusion injury, highlights are presented that relate to conditioning strategies of the heart with respect to molecular mechanisms and outcome in patients' cohorts, the influence of co-morbidities and medications, as well as the contribution of innate immune reactions in cardioprotection. Moreover, developmental or systems biology approaches bear great potential in systematically uncovering unexpected components involved in ischemia-reperfusion injury or heart regeneration. Based on the characterization of particular platelet integrins, mitochondrial redox-linked proteins, or lipid-diol compounds in cardiovascular diseases, their targeting by newly developed theranostics and technologies opens new avenues for diagnosis and therapy of myocardial infarction to improve the patients' outcome.
AU  - Cabrera-Fuentes,HA
AU  - Aragones,J
AU  - Bernhagen,J
AU  - Boening,A
AU  - Boisvert,WA
AU  - Bøtker,HE
AU  - Bulluck,H
AU  - Cook,S
AU  - Di,Lisa F
AU  - Engel,FB
AU  - Engelmann,B
AU  - Ferrazzi,F
AU  - Ferdinandy,P
AU  - Fong,A
AU  - Fleming,I
AU  - Gnaiger,E
AU  - Hernández-Reséndiz,S
AU  - Kalkhoran,SB
AU  - Kim,MH
AU  - Lecour,S
AU  - Liehn,EA
AU  - Marber,MS
AU  - Mayr,M
AU  - Miura,T
AU  - Ong,S-B
AU  - Peter,K
AU  - Sedding,D
AU  - Singh,MK
AU  - Suleiman,MS
AU  - Schnittler,HJ
AU  - Schulz,R
AU  - Shim,W
AU  - Tello,D
AU  - Vogel,C-W
AU  - Walker,M
AU  - Li,QOY
AU  - Yellon,DM
AU  - Hausenloy,DJ
AU  - Preissner,KT
DO  - 10.1007/s00395-016-0586-x
PY  - 2016///
SN  - 0300-8428
TI  - From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research"
T2  - Basic Research in Cardiology
UR  - http://dx.doi.org/10.1007/s00395-016-0586-x
UR  - https://www.ncbi.nlm.nih.gov/pubmed/27743118
VL  - 111
ER  -
Download